Chapter 223

Roche's speech soon spread.

Many senior experts in the investment sector said: "there is a saying in China that" if you can't eat grapes, you can say sour grapes! " I think it's a kind of jealousy for Roche to scold Henry Williams for his stupid money! As we all know, Henry Williams is a legend in the investment field, and is recognized as the most investment minded person in the world! He has invested in many enterprises that we know or don't know, but just a little bit of what we know can deeply shock everyone

"This time, Henry Williams is determined to buy Genentech, and his attitude and determination are stronger than ever! This shows that this company has great investment potential in his eyes! "

"So we can wait and see if Genentech can... Oh, no, it should be called geneumbrella now!"

"We can wait and see what kind of answers gene umbrella can give Henry in the future! But I think it's going to be a very beautiful answer

In addition to the experts' support for Henry, many netizens also expressed their support for Henry with comments on the Internet!

"Roche pharmaceutical is a fart. What's the big deal? I dare to laugh at Henry Williams and ask the richest man to take it away!"

"The total market value of Roche pharmaceutical is less than half of that of Henry Williams. It's so arrogant. Why not kill it!"

"Objectively speaking, Henry Williams spent $4 billion to acquire 65% of Genentech, which is a bit high. However, it is normal for a company with huge development potential to acquire at a premium. Roche pharmaceutical lost in the competition, and finally became angry and ridiculed Henry Williams, which was stingy and had no measure! "

"I would like to say that Henry Williams never failed in his investment, waiting for Roche to be beaten in the face!"

"Sit together!"

"The same seat?"?? I'm full of love... "

“……”

Roche ridicules Henry, how can Henry give up?

Two weeks later, a news came out from European newspapers: Roche officially launched the acquisition of Nikolay laboratories, a famous over-the-counter drug company in Europe!

Henry heard the news, immediately the first reaction, cut Hu!!!

If Roche acquired Nikolay laboratories, it will have a larger share in the European OTC market!

When Henry first heard about Nikolay lab, he thought it was Nikolay Tesla's lab. But there must be someone else involved in drug development!

But anyway, Henry decided to muddle the water.

Non prescription drugs refer to the drugs that can be purchased for the convenience of the public, under the premise of ensuring the safety of drug use, and after being regulated or approved by the national health administration department, without the need for doctors or other medical professionals to write prescriptions. In short, they are the drugs allowed to be sold in pharmacies!

Many of the drugs developed by Roche are over-the-counter drugs. If we buy Nikolay lab, they will complement each other!

At present, the drugs developed by gene umbrella company are all prescription drugs, which must be purchased and used under the guidance of professional doctors!

So gene umbrella doesn't need to rush to buy over-the-counter drug companies.

But why not do something that can block Roche?

In addition, the acquisition of Nicholas lab is a profitable company. What's more, it can retaliate against Roche. Nikolay lab is of great significance to Roche. It turns out that the competition between the two sides, each other's prices can not be too high, naturally will lead to reduced profits!

But once merged, it's a monopoly. What's the price?

Change the packaging, put it on the market as a new product, and then the price goes up a little bit

Henry thought that even if he could not acquire Nikolay lab in the end, he could make Roche spend more money!

However, this kind of trouble, do not have to Henry himself, send some hands on it.

Not long after that, Roche learned that gene umbrella company was going to buy Nikolay laboratory. Hearing the news, Roche almost wanted to curse her. You say that you are a biopharmaceutical company developing prescription drugs to acquire traditional chemical companies of over-the-counter drugs. The technical specialty is totally out of line. What's the trouble?!!

Roche pharmaceutical company will hate Henry teeth itch, this matter is certainly his leading, he this is retaliation!!!

Originally, Nikolay lab was about to agree to its acquisition conditions. However, as soon as gene umbrella company got involved, Nikolay lab immediately changed its tone and thought, since there are two big companies that want to acquire our company, I can't do anything about it. Who can give us more money? The representative of Roche pharmaceutical shook his head when he saw this. He said, "it's going to bleed a lot."

Nikolay lab doesn't care whether gene umbrella is a genuine acquisition or a special troublemaker for Roche. Welcome the coming of gene umbrella! Subsequently, the two sides held many close negotiations!

Nikolay wants to sell it at a high price and show it to Roche.

Gene umbrella is the same, so the two sides hit it off, very tacit performance!

However, if Roche just let it go, the gene umbrella may easily acquire Nikolay Lab! But if Roche pays a high price, gene umbrella may quit. Of course, the merger of the company, has a lot of money. But the research and development of new products need a lot of money. Gene umbrella company keeps money, will increase investment in scientific research!

Gene umbrella company, this is yangmou, make it clear not to let Roche pharmaceutical better.

Roche has to suffer this loss for the distribution of over-the-counter drugs in Europe.

Immediately, Roche raised its offer to Nikolay laboratories. Originally, it wanted to buy it for $1 billion, but now it has increased by $100 million!

But before long, it came out that gene umbrella company offered us $1.11 billion to Nikolay Lab!

Pop!!!

The sound of clapping the table suddenly rang out in the large conference room of Roche pharmaceutical!

"The gene umbrella company must be against us on purpose!"

"Isn't it in the air? In addition, Nikolay lab also cooperated with them, pretending to be intimate, thinking that we didn't know they were acting? "

"It seems that the money we made before will be spit out again now..."

"Damn, I won't buy Nikolay lab at all!"

"If we don't take over, should we let gene umbrella take over. After that, isn't our European back garden on fire

"After all, we still want to buy Nikolay Lab! We're going to raise the price, and we're going to pay $1.2 billion! "

"Well, what if gene umbrella offered us $1.21 billion? If we don't pay a high price, gene umbrella company will follow us all the time! In this way, it's better to pay a high price directly and let it retreat in the face of difficulties! If it wants to increase its price, we will give up this acquisition! "

"Well, that's right! Just quote a high price. Otherwise, for every price we offer, it will only increase by 10 million dollars, and it will always brush our face! "

"Well, I agree!"

“……”

Then, people at Roche were thinking about how much price to offer?

After an hour's discussion, it was finally decided to bid $1.5 billion!

Nikolay lab was very excited about the price. The representative of gene umbrella asked Henry if he wanted to continue to increase the price. Henry said with a smile, "no, the acquisition of Nikolay lab has not played a big role in us! Our company's development direction is biotechnology. If there is a suitable biotechnology company, it can be acquired! "

"Well, I see!"

After the gene umbrella representative hung up the phone, he replied to Nikolay lab that the gene umbrella company gave up the acquisition!

Nikolay lab is a little disappointed, but it is very satisfied that it can raise the purchase price to $1.5 billion due to the competition of gene umbrella.

Before long, Roche signed a contract with Nikolay laboratories and completed the acquisition!

At the press conference, after the chairman of Roche finished his speech, a reporter asked, "is it stupid for your company to spend US $1.5 billion on the acquisition of Nikolay laboratories with a market value of only US $1 billion?"